Tempest Therapeutics Files Q1 2025 10-Q
Ticker: TPST · Form: 10-Q · Filed: May 13, 2025 · CIK: 1544227
| Field | Detail |
|---|---|
| Company | Tempest Therapeutics, Inc. (TPST) |
| Form Type | 10-Q |
| Filed Date | May 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financials
TL;DR
**Tempest Therapeutics Q1 2025 10-Q filed. Check financials.**
AI Summary
Tempest Therapeutics, Inc. filed its Q1 2025 10-Q report on May 13, 2025, for the period ending March 31, 2025. The company, formerly known as OvaScience, Inc. and Millendo Therapeutics, Inc., is involved in pharmaceutical preparations. Key financial details and operational updates for the first quarter of 2025 are presented in this filing.
Why It Matters
This filing provides investors with the latest financial performance and operational status of Tempest Therapeutics for the first quarter of 2025, crucial for understanding the company's trajectory.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Tempest Therapeutics faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Players & Entities
- Tempest Therapeutics, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of the reporting period
- 20250513 (date) — Filing date
- Millendo Therapeutics, Inc. (company) — Former company name
- OvaScience, Inc. (company) — Former company name
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
- 451472564 (ein) — Employer Identification Number
- DE (state) — State of incorporation
- 415-798-8589 (phone) — Business phone number
- 001-35890 (sec_file_number) — SEC file number
FAQ
What is the reporting period for this 10-Q filing?
The reporting period for this 10-Q filing is the first quarter of 2025, ending on March 31, 2025.
When was this 10-Q filed with the SEC?
This 10-Q was filed on May 13, 2025.
What industry does Tempest Therapeutics operate in?
Tempest Therapeutics operates in the Pharmaceutical Preparations industry, classified under SIC code 2834.
Has Tempest Therapeutics operated under different names previously?
Yes, Tempest Therapeutics was formerly known as Millendo Therapeutics, Inc. and prior to that, OvaScience, Inc.
What is the company's state of incorporation?
The company is incorporated in Delaware (DE).
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 13, 2025 regarding Tempest Therapeutics, Inc. (TPST).